XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests in Operating Subsidiaries
Treasury Stock, Common
Beginning balance (in shares) at Dec. 31, 2021   350,000          
Beginning balance at Dec. 31, 2021   $ 14,753          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ 2,392          
Ending balance (in shares) at Jun. 30, 2022   350,000          
Ending balance at Jun. 30, 2022   $ 17,145          
Beginning balance (in shares) at Dec. 31, 2021     48,807,748        
Beginning balance at Dec. 31, 2021 $ 430,475   $ 49 $ 648,389 $ (181,724) $ 11,042 $ (47,281)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss including noncontrolling interests in subsidiaries (120,756)       (134,769) 14,013  
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value (2,392)     (2,392)      
Dividend on Series A Redeemable Convertible Preferred Stock (1,399)     (1,399)      
Issuance of common stock for vesting of restricted stock units (in shares)     175,501        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     242,667        
Compensation expense for share-based awards 2,257     2,257      
Repurchase of common stock (in shares)     (8,488,534)        
Repurchase of common stock (39,508)   $ (8)       (39,500)
Ending balance (in shares) at Jun. 30, 2022     40,622,465        
Ending balance at Jun. 30, 2022 268,174   $ 41 646,352 (316,493) 25,055 (86,781)
Beginning balance (in shares) at Mar. 31, 2022   350,000          
Beginning balance at Mar. 31, 2022   $ 15,904          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ 1,241          
Ending balance (in shares) at Jun. 30, 2022   350,000          
Ending balance at Jun. 30, 2022   $ 17,145          
Beginning balance (in shares) at Mar. 31, 2022     46,754,930        
Beginning balance at Mar. 31, 2022 345,472   $ 47 647,640 (254,990) 11,042 (58,267)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss including noncontrolling interests in subsidiaries (47,490)       (61,503) 14,013  
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value (1,241)     (1,241)      
Dividend on Series A Redeemable Convertible Preferred Stock (699)     (699)      
Issuance of common stock for vesting of restricted stock units (in shares)     160,501        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     (50,000)        
Shares withheld related to net share settlement of share-based awards (in shares)     (96,147)        
Shares withheld related to net share settlement of share-based awards (431)     (431)      
Compensation expense for share-based awards 1,083     1,083      
Repurchase of common stock (in shares)     (6,146,819)        
Repurchase of common stock (28,520)   $ (6)       (28,514)
Ending balance (in shares) at Jun. 30, 2022     40,622,465        
Ending balance at Jun. 30, 2022 268,174   $ 41 646,352 (316,493) 25,055 (86,781)
Beginning balance (in shares) at Dec. 31, 2022   350,000          
Beginning balance at Dec. 31, 2022   $ 19,924          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ 3,230          
Ending balance (in shares) at Jun. 30, 2023   350,000          
Ending balance at Jun. 30, 2023   $ 23,154          
Beginning balance (in shares) at Dec. 31, 2022     43,484,867        
Beginning balance at Dec. 31, 2022 269,322   $ 43 663,284 (306,789) 11,042 (98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss including noncontrolling interests in subsidiaries (9,332)       (9,332) 0  
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value (3,230)     (3,230)      
Dividend on Series A Redeemable Convertible Preferred Stock (1,400)     (1,400)      
Stock options exercised (in shares)     59,568        
Issuance of common stock for vesting of restricted stock units (in shares)     313,351        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     (34,167)        
Shares withheld related to net share settlement of share-based awards (in shares)     (137,577)        
Shares withheld related to net share settlement of share-based awards (595)     (595)      
Compensation expense for share-based awards 1,351     1,351      
Ending balance (in shares) at Jun. 30, 2023     58,754,795        
Ending balance at Jun. 30, 2023 335,433   $ 58 738,712 (316,121) 11,042 (98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock options exercised 206     206      
Beginning balance (in shares) at Mar. 31, 2023   350,000          
Beginning balance at Mar. 31, 2023   $ 21,478          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ 1,676          
Ending balance (in shares) at Jun. 30, 2023   350,000          
Ending balance at Jun. 30, 2023   $ 23,154          
Beginning balance (in shares) at Mar. 31, 2023     58,551,798        
Beginning balance at Mar. 31, 2023 355,687   $ 58 740,187 (297,342) 11,042 (98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss including noncontrolling interests in subsidiaries (18,779)       (18,779) 0  
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value (1,676)     (1,676)      
Dividend on Series A Redeemable Convertible Preferred Stock (700)     (700)      
Stock options exercised (in shares)     59,568        
Issuance of common stock from the Rights Offering, Shares     15,068,753        
Issuance of common stock for vesting of restricted stock units (in shares)     202,810        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     (16,667)        
Shares withheld related to net share settlement of share-based awards (in shares)     (42,714)        
Shares withheld related to net share settlement of share-based awards (179)     (179)      
Rights Offering 79,111   $ 15 79,096      
Compensation expense for share-based awards 874     874      
Ending balance (in shares) at Jun. 30, 2023     58,754,795        
Ending balance at Jun. 30, 2023 335,433   $ 58 738,712 $ (316,121) $ 11,042 $ (98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock options exercised $ 206     $ 206